The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients

Blood

Volumn 103, Issue 5, 2004, Pages 1770-1778

  Markel, Gal ^b   Mussaffi, Huda ^b   Ling, Khoon Lin ^b   Salio, Mariolina ^b   Gadola, Stephan ^b   Steuer, Guy ^b   Blau, Hannah ^b   Achdout, Hagit ^b   De Miguel, María ^b   Gonen Gross, Tsufit ^b   Hanna, Jacob ^b   Arnon, Tal I ^b   Qimron, Udi ^b   Volovitz, Ilan ^b   Eisenbach, Lea ^b   Blumberg, Richard S ^b   Porgador, Angel ^b   Cerundolo, Vincenzo ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CELL RECEPTOR; KILLER CELL INHIBITOR RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN NKP46; PROTEIN TAP2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; BRONCHIECTASIS; CASE REPORT; CELL KILLING; CLINICAL FEATURE; CYTOTOXICITY; HUMAN; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD; SEROUS OTITIS MEDIA; SINUSITIS; TUMOR CELL DESTRUCTION;

EID: 10744232230     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-06-2114     Document Type: Article

References (40)

1. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727-729.
2. Cantoni C, Bottino C, Vitale M, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 1999;189:787-796.
3. Mandelboim O, Malik P, Davis DM, Chang HJ, Boyson JE, Strominger JL. Human CD16 as a lysis receptor mediating direct natural killer (NK) cell cytotoxicity. Proc Natl Acad Sci U S A. 1999;96:5640-5644.
4. Pende D, Parolini S, Pessino A, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 1999;190:1505-1516.
5. Pessino A, Sivori S, Bottino C, et al. Molecular cloning of NKp46: novel member of the immunoglobulin superfamily involved in triggering of natural cytotocxicity. J Exp Med. 1998;188:953-960.
6. Wu J, Song Y, Bakker AB, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 1999;285:730-732.
7. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol. 2001;9:2680-2689.
8. Mandelboim O, Lieberman N, Lev M, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 2001;409:1055-1060.
9. Braud VM, Allan DS, O'Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998;391:795-799.
10. Colonna M, Navarro F, Bellon T, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 1997;186:1809-1818.
11. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 1999;17:875-904.
12. Moretta A, Bottino C, Vitale M, et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol. 1996;14:619-648.
13. Cantoni C, Bottino C, Augugliaro R, et al. Molecular and functional characterization of Irp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol. 1999;29:3148-3158.
14. Falco M, Biassoni R, Bottino C, et al. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med. 1999;190:793-801.
15. Markel G, Lieberman N, Katz G, et al. CD66a interactions between human melanoma and NK cells: a novel class I MHC independent inhibitory mechanism of cytotoxicity. J Immunol. 2002;168:2803-2810.
16. Thies A, Moll I, Berger J, et al. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol. 2002;20:2530-2536.
17. Laack E, Nikbakht H, Peters A, et al. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. J Clin Oncol. 2002;20:4279-4284.
18. Markel G, Wolf D, Hanna J, et al. Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J Clin Invest. 2002;110:943-953.
19. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK recognition. Immunol Today. 1990;11:237-244.
20. Vitale M, Zimmer J, Castriconi R, et al. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood. 2002;99:1723-1729.
21. Salcedo M, Ljunggren HG. Natural killer cells in MHC class I deficient mice. Chem Immunol. 1996;64:44-58.
22. Katz G, Markel G, Mizrahi S, Arnon TI, Mandelboim O. Recognition of human leukocyte antigen (HLA)-Cw4 but not -Cw6 by the natural killer cell receptor KIR2DS4. J Immunol. 2001;166:7260-7267.
23. Morales VM, Christ A, Watt SM, et al. Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). J Immunol. 1999;163:1363-1370.
24. Spies T, Bresnahan M, Bahram S, et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature. 1990;348:744-747.
25. DeMars R, Chang CC, Rudersdorf RA. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line. Hum Immunol. 1983;8:123-139.
26. Mandelboim O, Reyburn HT, Vales-Gomez M, et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med. 1996;184:913-922.
27. de la Salle H, Hanau D, Fdcker D, et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science. 1994;265:237-241.
28. Sivori S, Pende D, Bottino C, et al. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells: correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol. 1999;29:1656-1666.
29. Kammerer R, Hahn S, Singer BB, Lou JS, von Kleist S. Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation. Eur J Immunol. 1998;28:3664-3674.
30. Mandelboim O, Reybum HT, Vales-Gomez M, et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med. 1996;184:913-922.
31. Oikawa S, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H. Homotypic and heterotypic Ca+ +-in-dependent cell adhesion activities of biliary glycoprotein, a member of carcinoembryonic antigen family, expressed on CHO cell surface. Biochem Biophys Res Comm. 1992;186:881-887.
32. Watt SM, Teixeira AM, Zhou GQ, et al. Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. Blood. 2001;98:1469-1479.
33. Pende D, Cantoni C, Rivera P, et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol. 2001;4:1076-1086.
34. Dorfman JR, Zerrahn J, Coles MC, Raulet DH. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1-mice. J Immunol. 1997;159:5219-5225.
35. Sivori S, Falco M, Marcenaro E, et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc Natl Acad Sci U S A. 2002;99:4526-4531.
36. Matamoros N, Mila J, Llano M, et al. Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency. Clin Exp Immunol. 2001;125:274-282.
37. Poy MN, Yang Y, Rezaei K, et al. CEACAM1 regulates insulin clearance in liver. Nat Genet. 2002;30:270-276.
38. Rojas M, Fuks A, Stanners CP. Biliary glycoprotein, a member of the immunoglobulin supergene family, functions in vitro as a Ca2(+)-dependent intercellular adhesion molecule. Cell Growth Differ. 1990;1:527-533.
39. Huang J, Hardy JD, Sun Y, Shively JE. Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F. J Cell Sci. 1999;112:4193-4205.
40. Moins-Teisserenc HT, Gadola SD, Celia M, et al. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules. Lancet. 1999;354:1598-1603.